Affibody AB

Affibody provides molecular imaging agents for visualizing HER2-expressing cancer

Published in Medical Imaging Law Weekly, May 30th, 2006

Affibody AB announced that Cancer Research, the publication of American Association of Cancer Research (AACR), has published an article by Affibody and collaborators on the development and evaluation of a new targeting molecule that can be used for visualization of HER2-expressing cancers.

The article, entitled "Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule," is authored by A. Orlova and co-workers and appeared in print form of the April 15th issue of Cancer Research (Volume 66, pages 4339-4348).

The authors reported on the development of a HER2-specific Affibody molecule having an extremely high affinity (22...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly

Source: Medical Imaging Law Weekly (2006-05-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry